Impact of Intertransverse Process Block on Postoperative Acute Pain in Patients Undergoing Coronary Artery Bypass Grafting Via Median Sternotomy: A Prospective, Randomized Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This prospective, randomized controlled trial aims to evaluate the effect of bilateral intertransverse process block (ITPB) on acute postoperative pain in patients undergoing coronary artery bypass grafting (CABG) via median sternotomy. Patients will be randomly assigned to receive either ITPB or placebo (saline) injection prior to surgery. Postoperative pain scores, opioid consumption, and recovery quality will be assessed during the first 24 hours following extubation.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years
• Elective coronary artery bypass grafting (CABG) via median sternotomy planned
• Able to provide written informed consent
• Able to communicate symptoms reliably with the research team
Locations
Other Locations
Turkey
University of Health Sciences, Konya City Hospital
RECRUITING
Konya
Contact Information
Primary
Mustafa Aydemir
drmustafaaydemir02@gmail.com
+905378725583
Time Frame
Start Date: 2025-05-05
Estimated Completion Date: 2025-11-02
Participants
Target number of participants: 70
Treatments
Experimental: ITPB Group
Patients in this group will receive a bilateral intertransverse process block (ITPB) with 0.25% bupivacaine (20 mL per side) under ultrasound guidance before coronary artery bypass grafting.
Placebo_comparator: Control Group
Patients in this group will receive bilateral saline injections (20 mL per side) at the same anatomical site under ultrasound guidance prior to surgery.
Related Therapeutic Areas
Sponsors
Collaborators: Konya City Hospital
Leads: Mustafa Aydemir